Irene Aracil | Congenital Heart Defects | Young Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Irene Aracil | Congenital Heart Defects | Young Researcher Award

Hospital Fundación Alcorcón | Spain

Ms. Irene Aracil is a medical specialist in Obstetrics and Gynecology at Hospital Universitario Fundación Alcorcón, recognized for her expertise in maternal and fetal medicine. She completed advanced training in obstetrics, gynecology, and human reproduction at leading Spanish institutions and is pursuing a doctoral degree focused on severe preeclampsia and its long-term cardiovascular effects on women’s health. Her research aims to improve maternal and perinatal outcomes through evidence-based and collaborative approaches. Ms. Aracil Moreno has authored 34 indexed publications and several book chapters, with an h index of 5 and a growing number of citations. Her main areas of study include high risk pregnancies, hypertensive disorders of pregnancy, fertility, and gynecological oncology. She has led and contributed to case control and cohort studies on preeclampsia, maternal outcomes in women with heart disease, and acute kidney injury in pregnancy, as well as meta analyses on triplet pregnancies and uterine sarcomas. Through her multidisciplinary collaborations, she bridges obstetrics and cardiovascular research, providing insights into how pregnancy complications affect long-term health. Her scientific work and clinical dedication continue to advance women’s health, making her a leading young researcher in the field of obstetrics and gynecology.

Profiles: Scopus | Orcid

Featured Publications

Aracil Moreno, I., Prieto-Arévalo, R., Ortega-Abad, V., Martín-Manzano, V., Pérez-Burrel, L., Fraile-López, A., Devesa-Cordero, C., Yllana-Pérez, F., Ortega, M. A., & De León-Luis, J. A. (2024). Maternal and perinatal outcomes in pregnant women with heart disease: A case-control study. Journal of Clinical Medicine, 13(17), 5084.

Aracil Moreno, I., Rodríguez-Benitez, P., Ruiz-Minaya, M., Bernal Claverol, M., Ortega Abad, V., Hernández Martin, C., Pintado Recarte, P., Yllana, F., Oliver-Barrecheguren, C., Alvarez-Mon, M., Ortega, M. A., & De Leon-Luis, J. A. (2024). Perinatal characteristics in patients with severe preeclampsia: A case-control nested cohort study. International Journal of Environmental Research and Public Health.

Aracil Moreno, I., Caballero Martín, S., Ceballos Medina, A., Díaz-Crespo, F. J., Navarro, [initial missing], Ortega Abad, V., León-Luis, J. A., & Mata, F. (2021). Perinatal findings and outcomes in a very rare congenital bulky retroperitoneal Ewing sarcoma: A case report. Pediatric Hematology Oncology Journal.

Rodríguez-Benitez, P., Aracil Moreno, I., Oliver Barrecheguren, C., Cuñarro López, Y., Yllana, F., Pintado Recarte, P., et al. (2021). Maternal-perinatal variables in patients with severe preeclampsia who develop acute kidney injury. Journal of Clinical Medicine, 10(23), 5629.

Ruiz-Minaya, M., Mendizabal-Vicente, E., Vasquez-Jimenez, W., Perez-Burrel, L., Aracil-Moreno, I., Agra-Pujol, C., Bernal-Claverol, M., Martínez-Bernal, B. L., Muñoz-Fernández, M., Morote-Gonzalez, M., Ortega, M. A., Lizarraga-Bonelli, S., & De Leon-Luis, J. A. (2022). Retrospective analysis of patients with gynaecological uterine sarcomas in a tertiary centre. Journal of Personalized Medicine, 12(2), 222.

Yiqun Shi | Cardiology | Best Researcher Award 2025

Published on by Cardiology and Cardiovascular Medicine

Dr. Yiqun Shi | Cardiology | Best Researcher Award

Beijing Friendship Hospital | Capital Medical University | China

Author Profile

Orcid

Early Academic Pursuits

Dr. Yiqun Shi began his academic journey at the Health Science Center of Peking University, where he pursued Clinical Medicine. His early training laid a strong foundation in medical sciences, combining theoretical knowledge with practical exposure. He showcased exceptional dedication and consistently demonstrated a broad vision that extended beyond traditional clinical practices. This formative stage not only strengthened his medical competence but also nurtured his curiosity toward innovative approaches in cardiovascular research.

Professional Endeavors

Building upon his undergraduate foundation, Dr. Shi advanced his medical career at Peking University People’s Hospital, where he successfully completed his doctoral training in Clinical Medicine. His professional path was marked by perseverance, rigorous research, and continuous skill development. He actively engaged in clinical cardiology and emergency medicine, balancing practical medical responsibilities with research pursuits. His dedication to bridging patient care with scientific inquiry has been a defining characteristic of his career trajectory.

Contributions And Research Focus

Dr. Shi’s research primarily focuses on myocardial bridging, a specialized area within cardiovascular medicine. His investigations explore the structural and functional impact of myocardial bridging on coronary anatomy and hemodynamics. Alongside this, he developed expertise in non-invasive hemodynamic assessment methods, aligning his work with contemporary technological advancements in cardiovascular diagnostics. Additionally, his independent study of artificial intelligence and its application to clinical research allowed him to contribute to the development of innovative deep learning models for cardiovascular assessment.

Impact And Influence

The significance of Dr. Shi’s research lies in its ability to inform and refine clinical practices in cardiology. By enhancing the understanding of coronary myocardial bridging, his contributions provide valuable insights into diagnostic approaches and patient management strategies. His work bridges clinical application with technology-driven solutions, thereby influencing not only cardiologists but also the wider medical research community. His ability to merge traditional clinical expertise with modern technological tools places him at the forefront of emerging trends in cardiovascular medicine.

Academic Cites

Dr. Shi has published widely in peer-reviewed international journals, with his work receiving citations from academic peers and fellow researchers in cardiology and emergency medicine. His publications highlight both clinical case insights and advanced methodological research, reflecting the interdisciplinary nature of his academic endeavors. The growing recognition of his work demonstrates his increasing influence in shaping discussions around myocardial bridging and cardiovascular diagnostics.

Legacy And Future Contributions

Looking ahead, Dr. Shi is committed to advancing innovative, patient-centered approaches in cardiology. His legacy lies in combining clinical medicine with cutting-edge technologies such as artificial intelligence and non-invasive assessment techniques. By continuing to investigate myocardial bridging and related cardiovascular conditions, he aims to create pathways that integrate early detection, precision diagnostics, and improved patient outcomes. His contributions are likely to inspire future researchers, strengthening the bridge between traditional medicine and evolving scientific innovations.

Conclusion

Dr. Yiqun Shi represents the embodiment of academic excellence, professional dedication, and research-driven innovation in the field of cardiology. His career reflects a consistent effort to integrate clinical practice with technological progress, addressing pressing challenges in cardiovascular medicine. Through his pioneering work on myocardial bridging and his commitment to harnessing artificial intelligence, Dr. Shi stands as a promising contributor to both present and future advancements in global medical research.

Notable Publication

"Impact of Myocardial Bridging on Hemodynamics Evaluated by Coronary Angiography-Derived Fractional Flow Reserve"

Authors: Yiqun Shi, Jian Liu
Journal: The American Journal of Cardiology
Year: 2025

Yixin Xu | Cardiovascular Researches | Best Researcher Award 2025

Published on by Cardiology and Cardiovascular Medicine

Dr. Yixin Xu | Cardiovascular Researches | Best Researcher Award

The First Affiliated Hospital of Army Medical University | China

Author Profile

Orcid

Early Academic Pursuits

YiXin Xu began her medical journey at Xinjiang Medical University, where she pursued an undergraduate degree in Clinical Medicine. Her strong academic performance and dedication to patient care inspired her to continue postgraduate studies in Internal Medicine, specializing in cardiovascular medicine. This early pursuit of advanced knowledge built the foundation for her growing expertise in both clinical practice and research.

Professional Endeavors

Her professional development included an internship at the Traditional Chinese Medicine Hospital of Shapingba District in Chongqing City, where she gained valuable clinical exposure. She then undertook standardized resident physician training at the First Affiliated Hospital of Xinjiang Medical University. During this period, she successfully managed patient care, independently handled on-duty responsibilities, and developed expertise in treating conditions such as coronary heart disease, hypertension, and pulmonary hypertension.

Contributions And Research Focus

She has contributed to several important research projects that bridge clinical practice with scientific inquiry. These include investigating the relationship between vitamin D, parathyroid hormone, and circadian rhythms in blood pressure regulation among patients with hypertension. She also participated in the Step-Pre Project and the "iCare-Me" initiative, both of which aim to improve patient outcomes through innovative approaches. Additionally, she contributed to the creation of a predictive model for heart failure in patients with coronary heart disease, based on metabolic biomarkers, highlighting her focus on precision medicine and translational research.

Clinical Expertise

Through her training, she became proficient in both the theoretical and practical aspects of internal medicine. She is skilled in the standardized documentation of medical records, surgical notes, and disease course records. Her technical expertise includes performing essential clinical procedures such as abdominal puncture and bone marrow puncture. These abilities underscore her readiness to practice medicine at a high professional standard.

Impact And Influence

Her dual contributions as a clinician and researcher have positioned her to influence both patient care and the scientific community. By combining clinical experience with data-driven research, she advances understanding in cardiovascular disease while improving strategies for patient management. Her work reflects a commitment to bridging the gap between medical research and real-world healthcare delivery.

Academic Cites

Her scholarly contributions have been acknowledged through participation in collaborative studies and cited within ongoing cardiovascular research initiatives. These academic references reflect her growing influence and recognition within the medical research community.

Legacy And Future Contributions

Looking forward, she aspires to strengthen predictive models for cardiovascular disease and enhance evidence-based treatment protocols. Her career vision includes contributing to global medical research networks, publishing impactful studies, and advancing patient care practices through innovation and collaboration.

Conclusion

YiXin Xu exemplifies the qualities of a dedicated physician and researcher. With her academic excellence, clinical expertise, and meaningful research contributions, she is poised to make significant advancements in cardiovascular medicine. Her commitment to innovation and patient-centered care ensures that she will leave a lasting impact on both clinical practice and medical science.

Notable Publication

"Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension"

Authors: Yixin Xu, Changjiang Deng, Xiaohui Liang
Journal: Clinical and Experimental Hypertension
Year: 2025

Yusheng Liu | Interventional Cardiology | Best Researcher Award 

Published on by Cardiology and Cardiovascular Medicine

Prof. Yusheng Liu | Interventional Cardiology | Best Researcher Award

The Second Hospital of Shandong University | China

Author Profile:

Scopus

🩺 PROF. YUSHENG LIU – A PIONEER IN HEART FAILURE & ECHOCARDIOGRAPHY

🎓 EARLY ACADEMIC PURSUITS

Prof. Yusheng Liu began his illustrious academic journey in Clinical Medicine at Taishan Medical School (now The First Medical University of Shandong), earning his Bachelor’s degree (1995–2000). His quest for deeper knowledge led him to pursue a Master’s degree in Internal Medicine with a focus on Cardiovascular Disease at Shandong University School of Medicine (2004–2007), followed by an M.D. in Cardiovascular Medicine (2010–2013) from the same institution.

👨‍⚕️ PROFESSIONAL ENDEAVORS

Since July 2000, Prof. Liu has served at the Second Hospital of Shandong University, currently holding the title of Deputy Chief Physician of Cardiovascular Medicine, Associate Professor, and Doctoral Supervisor. He also leads the Cardiac Care Unit (CCU) and plays a pivotal role in guiding the next generation of clinicians as a Master’s tutor.

His career also extends into professional societies, where he holds several leadership roles, including:

  • Executive Director, China Ultrasonic Medical Engineering Society (Echocardiography Division)

  • Vice Chairman, Shandong Ultrasound in Medicine Engineering Institute

  • Youth Leader, Shandong Medical Health System

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON INTERVENTIONAL CARDIOLOGY

Prof. Liu has dedicated his research to heart failure, echocardiography, coronary artery disease, and atherosclerosis. He has:

  • Led or contributed to multiple National Key Projects such as 973, 863, and the National Natural Science Foundation

  • Chaired international collaborations like the Macau SAR Science & Technology Fund

  • Focused heavily on biomarker-based diagnostics, ventricular function in diabetes, and plaque stability in coronary syndromes

His projects have bridged clinical and basic science, contributing to real-world patient improvements and high-impact academic knowledge.

🏆 IMPACT AND INFLUENCE

Prof. Liu’s work has been nationally and internationally recognized:

  • Two-time winner of National Science and Technology Progress Award

  • Recipient of multiple provincial awards including 4 second-place and 6 third-place Science & Tech Awards

  • Frequent keynote speaker at conferences such as:

    • 24th Great Wall International Cardiology Conference

    • 12th National Echo Cardiac Conference

    • 2016 Pharmacology & Ethnopharmacology Conference, Chicago, USA

He is also involved in clinical ethics, oncology cardiology, heart rehabilitation, and hypertension professional committees.

📚 ACADEMIC CITATIONS AND MEMBERSHIPS

Prof. Liu is a proud member of:

  • American Society of Echocardiography (ASE)

  • China Ultrasound Medical Engineering Society (Permanent Member)

  • Various Shandong Medical Associations across cardiology, ethics, and disaster medicine

His publications and research are cited in numerous national and international cardiovascular journals and conferences, further amplifying his impact on the global stage.

🧪 SCIENTIFIC PROJECTS (SELECTED)

Some of the noteworthy research projects under his leadership include:

  1. Huatong-Guokang Medical Scientific Research Project – Ministry of Education (2023)

  2. Clinical Elite Scientist Programme (2018)

  3. National Key R&D Plan (2022YFC3502100)

  4. Lipoprotein-Associated Phospholipase A2 and Plaque Stability (2014)

  5. JNK Pathway and Atherosclerosis Mechanism (2013)

  6. DPP-4 Inhibitors and Ventricular Function in Diabetic Patients (2013)

🏅 AWARDS AND HONORS

Prof. Liu has received:

  • Lecture Honorary Certificate – Pharmacology & Ethnopharmacology 2016

  • Shandong Soft Science Excellence Award

  • Outstanding Teaching Certificate – Weifang University (2016)

  • Advanced Medical Worker Honor – Phoenix Media

  • Scholarships from Shandong University and affiliated hospitals

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Yusheng Liu stands as a leading voice in the evolution of cardiovascular care in China and beyond. His multidisciplinary influence spans clinical excellence, scientific innovation, academic mentorship, and global collaboration.

In the years to come, his focus on integrating precision medicine, biomarkers, and advanced imaging will continue shaping the future of heart failure diagnostics, ultrasound cardiology, and clinical translational research. With a legacy rooted in innovation and education, he continues to inspire and uplift the cardiovascular medicine community.

📑 NOTABLE PUBLICATION

"Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome"

Authors: Xuguang Zhang, Zhiwei Huang, Xin Wang, Han Hao, Dali Fan, Martin Cadeiras, Yusheng Liu
Journal: Catheterization and Cardiovascular Interventions
Year: 2025

 

Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Prof. Wei Eric Wang, Southwest Hospital, Army Medical University, China

Prof. Wei Eric Wang is a distinguished medical professional based at Southwest Hospital, Army Medical University, in China. Renowned for his expertise in medical research and clinical practice, he has contributed significantly to the fields of surgery, healthcare management, and medical education. With numerous publications in peer-reviewed journals, Prof. Wang has established a reputation for pioneering studies in his area of specialization. He is also actively involved in advancing medical training, and his leadership at the hospital continues to shape healthcare innovation in China. His work has earned him recognition both nationally and internationally.

AUTHOR PROFILE

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS:

Dr. Wei (Eric) Wang pursued his medical education at the Third Military Medical University in Chongqing, China. He earned his M.D. in Clinical Medicine from 2000 to 2005. Following this, he completed his Ph.D. at the Institute of Burn Surgery, Southwest Hospital, at the same university between 2005 and 2010. His early academic endeavors laid the foundation for his expertise in cardiology and geriatric medicine.

🏥PROFESSIONAL ENDEAVORS:

Dr. Wang has held various prestigious positions throughout his career. He has been the Director of the Department of Geriatrics at Southwest Hospital since November 2022, demonstrating his leadership in the field. Prior to this, he served as Chief Physician and Professor in the Department of Cardiology at Daping Hospital, Army Medical University. His extensive experience includes roles such as Deputy Director, Associate Chief Physician, Attending Doctor, and Resident, reflecting his progressive career growth and expertise in cardiology and geriatrics.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Myocardial Infarction

Dr. Wang’s research is centered on new strategies for treating cardiovascular diseases, particularly myocardial infarction and heart failure. His primary areas of focus include:

  1. Mechanisms regulating cardiac regeneration.
  2. Translational and clinical studies for treating cardiovascular diseases.
  3. Translational and clinical research for preventing aging.

His work has significantly advanced the understanding of cardiac repair mechanisms and potential therapeutic interventions.

🌍IMPACT AND INFLUENCE:

Dr. Wang has played a crucial role in the field of cardiology and geriatrics. His research has contributed to innovative treatments that enhance cardiac regeneration and improve patient outcomes. As a leader in cardiovascular medicine, his influence extends beyond clinical practice to shaping future medical research and treatment methodologies.

📚ACADEMIC CITATIONS AND RECOGNITION:

Dr. Wang has an impressive list of publications in esteemed medical journals. Some of his notable works include:

  1. “Metabolic reprogramming: a byproduct or a driver of cardiomyocyte proliferation?” published in Circulation (2024).
  2. “Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ-NONO heteromer-induced DNA repair,” published in Basic Research in Cardiology (2022).
  3. “The Role of G Protein-Coupled Receptor Kinase 4 in Cardiomyocyte Injury after Myocardial Infarction,” published in European Heart Journal (2021).
  4. “Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury,” published in Circulation (2017).

These publications highlight his extensive contributions to cardiovascular research and his role in advancing medical knowledge in this domain.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Wang’s legacy is deeply rooted in his contributions to cardiovascular research, innovative treatment strategies, and leadership in geriatric medicine. As a distinguished professor and researcher, his work continues to shape the future of cardiology and geriatrics. His ongoing research and clinical innovations are expected to provide new breakthroughs in cardiac care and aging prevention, benefiting future generations of patients and medical professionals.

🚀CONCLUSION:

Prof. Wei Eric Wang is a distinguished cardiologist and geriatrician whose groundbreaking research and leadership have significantly impacted cardiovascular medicine. His dedication to innovation, patient care, and scientific discovery continues to inspire future generations. As Director of Geriatrics at Southwest Hospital, his work advances both clinical and translational medicine, improving lives worldwide. With numerous influential publications and a commitment to pioneering treatments, his contributions to cardiac regeneration and aging prevention are invaluable. His legacy in medicine and academia ensures a lasting impact, shaping the future of healthcare and research.

TOP NOTABLE PUBLICATIONS

  • Title: Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?
    Authors: Xiaokang Chen, Hao Wu, Ya Liu, Lingyan Liu, Steven R. Houser, Wei Eric Wang
    Journal: Circulation
    Year: 2024

  • Title: Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ–NONO heteromer-induced DNA repair
    Authors: Wenbin Fu, Hongmei Ren, Jialing Shou, Qiao Liao, Liangpeng Li, Yu Shi, Pedro A. Jose, Chunyu Zeng, Wei Eric Wang
    Journal: Basic Research in Cardiology
    Year: 2022

  • Title: The Protective Role of Yin‐Yang 1 in Cardiac Injury and Remodeling After Myocardial Infarction
    Authors: Yu Huang, Liangpeng Li, Hongmei Chen, Qiao Liao, Xiaoli Yang, Dezhong Yang, Xuewei Xia, Hongyong Wang, Wei Eric Wang, Lianglong Chen et al.
    Journal: Journal of the American Heart Association
    Year: 2021

  • Title: The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction
    Authors: Wei Eric Wang, Liangpeng Li, Fu W, Gong X, Chen Z, Tang L, Yang D, Liao Q, Xia X, Wu H et al.
    Journal: European Heart Journal
    Year: 2021

  • Title: An Aurora Kinase B-Based Mouse System to Efficiently Identify and Analyze Proliferating Cardiomyocytes
    Authors: Wei Eric Wang, Fu W, Liao Q, Li L, Shi Y, Zeng A, Zeng C, Wang WE
    Journal: Frontiers in Cell and Developmental Biology
    Year: 2020

  • Title: Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart
    Authors: Wei Eric Wang, Zhang Y, Wang WE, Zhang X, Li Y, Chen B, Liu C, Ai X, Zhang X, Tian Y et al.
    Journal: Circulation Research
    Year: 2019

  • Title: Noncoding RNA and Cardiomyocyte Proliferation
    Authors: Shuang Qu, Chunyu Zeng, Wei Eric Wang
    Journal: Stem Cells International
    Year: 2017

  • Title: Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury
    Authors: Wei Eric Wang, Wang WE, Li L, Xia X, Fu W, Liao Q, Lan C, Yang D, Chen H, Yue R et al.
    Journal: Circulation
    Year: 2017

  • Title: Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium
    Authors: Wei Eric Wang, Wang WE, Yang D, Li L, Wang W, Peng Y, Chen C, Chen P, Xia X, Wang H et al.
    Journal: Circulation Research
    Year: 2013

Christopher Coe | Cardiovascular Researches | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Christopher Coe | Cardiovascular Researches | Best Research Article Award

Prof. Christopher Coe, University of Wisconsin-Madison, United States

Prof. Christopher Coe is a distinguished professor emeritus in psychology at the University of Wisconsin-Madison, recognized for his pioneering work in psychoneuroimmunology and developmental psychobiology. With a career spanning leading institutions, he has made significant contributions to understanding the interaction of stress, immune function, and social behavior, earning numerous accolades for his research and teaching.

Author Profile:

Scopus Profile

Orcid Profile

Educational Details:

Prof. Christopher Coe, Professor Emeritus at the University of Wisconsin-Madison, is a distinguished expert in biological psychology and psychoneuroimmunology. He earned a B.A. in Anthropology (cum laude) with a minor in Biology from City College, City University of New York, in 1971, and a Ph.D. in Biological Psychology from Downstate Medical Center, SUNY, in 1976. Following this, he completed a postdoctoral fellowship in developmental psychobiology at Stanford University Medical School (1976-77). Prof. Coe’s career has been marked by groundbreaking research on the interplay between behavior, stress, and immune function, as well as exceptional contributions to teaching and academic leadership.

Professional Experience:

Prof. Christopher Coe has had an illustrious academic career spanning over five decades, beginning as a Lecturer at the American Museum of Natural History in New York (1970-71). He held key roles at Stanford University, including Postdoctoral Fellow (1976-77), Assistant Director of the Outdoor Primate Facility (1977-79), and Assistant Professor at the School of Medicine (1981-85). Joining the University of Wisconsin-Madison in 1985, he served as Associate Professor, Director of the Harlow Center for Biological Psychology, and later as Professor (1988-2022). Honored as the W.B. Cannon Professor of Biopsychology (2001-2022), he is now Professor Emeritus and Honorary Scholar.

Research Interests:

Prof. Christopher Coe’s research spans developmental psychobiology, psychoneuroimmunology, and sociophysiology. He investigates how early life experiences shape biological and psychological development, the interplay between stress, behavior, and immune system function, and the biological basis of social interactions and their effects on health and well-being.

Research Skills:

Prof. Christopher Coe specializes in designing and conducting longitudinal studies in developmental psychobiology, with expertise in psychoneuroimmunology and animal behavioral research. He is also proficient in sociophysiological measurement techniques and advanced data analysis, enabling a comprehensive understanding of the biological and behavioral dynamics underlying health and development.

Research Projects:

Prof. Christopher Coe has spearheaded pioneering research projects on the impact of stress and early life experiences on immune development, behavioral and physiological adaptations in primates, and the psychosocial factors influencing health and resilience throughout the lifespan.

Awards and Honors:

Prof. Christopher Coe has received numerous prestigious awards, including the Chancellor’s Award for Excellence in Teaching (1997), the WARF Professorship as W.B. Cannon Professor (2001), and the Norman Cousins Award for Psychoneuroimmunology Research (2001). Other honors include the Ziskind-Somerfield Award for Innovative Research (2004), the Hilldale Award for Teaching and Scholarship (2006), the P. Barchas Award for Sociophysiology Research (2008), and an Honorary Professorship from South China Normal University (2009). He also earned the Best Research in Health and Society accolade (2011) and the UW Board of Regents Teaching Excellence Award (2013).

Conclusion:

Prof. Christopher Coe’s career exemplifies excellence in academic leadership, innovative research, and impactful teaching. His contributions to psychology and biopsychology continue to inspire scholars and shape the understanding of health, behavior, and development.

Top Notable Publications:

Biobehavioral mechanisms underlying symptoms in cancer patients with chronic graft-versus-host disease

Authors: Hansen, J.L., Rumble, M.E., Coe, C.L., Hematti, P., Costanzo, E.S.

Year: 2025

Citations: 0

Non-invasive ventral cervical magnetoneurography as a proxy of in vivo lipopolysaccharide-induced inflammation

Authors: Bu, Y., Burks, J., Yang, K., Coleman, T.P., Lerman, I.

Year: 2024

Citations: 0

Higher inflammatory proteins predict future depressive symptom severity among adolescents with lower emotional clarity

Authors: Stephenson, A.R., Ka-Yi Chat, I., Bisgay, A.T., Abramson, L.Y., Alloy, L.B.

Year: 2024

Citations: 0

Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts

Authors: Turner, D.G.P., De Lange, W.J., Zhu, Y., Ralphe, J.C., Glukhov, A.V.

Year: 2024

Citations: 2

Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys

Authors: Coe, C.L., Nimityongskul, F., Lubach, G.R., Rancour, D., Schomburg, F.M.

Year: 2024

Citations: 0

Exercise does not cause post-exertional malaise in Veterans with Gulf War Illness: A randomized, controlled, dose–response, crossover study

Authors: Boruch, A.E., Barhorst, E.E., Rayne, T.J., Cook, D.B., Lindheimer, J.B.

Year: 2024

Citations: 1

Financial Hardship and Age-Related Decrements in Kidney Function among Black and White Adults in the Midlife in the United States Study

Authors: Surachman, A., Harhay, M., Santos, A.R., Almeida, D.M., Coe, C.L.

Year: 2024

Citations: 1

Lingering Effects of Early Institutional Rearing and Cytomegalovirus Infection on the Natural Killer Cell Repertoire of Adopted Adolescents

Authors: Wood, E.K., Reid, B.M., Sheerar, D.S., Gunnar, M.R., Coe, C.L.

Year: 2024

Citations: 1

Prognostic Performance of Hematological and Serum Iron and Metabolite Indices for Detection of Early Iron Deficiency Induced Metabolic Brain Dysfunction in Infant Rhesus Monkeys

Authors: Sandri, B.J., Kim, J., Lubach, G.R., Coe, C.L., Rao, R.B.

Year: 2024

Citations: 3

The Impact of Early and Recent Life Stress on Trajectories of Inflammatory Biomarkers in a Diverse Sample of Adolescents

Authors: Kautz, M.M., McArthur, B.A., Moriarity, D.P., Abramson, L.Y., Alloy, L.B.

Year: 2023

Citations: 4

Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr.Stephane Manzo-Silberman | Cardiology | Best Researcher Award 

 Dr. Stephane Manzo-Silberman, APHP Sorbonne University, France

Dr. Stephane Manzo-Silberman is a renowned cardiologist at Assistance Publique-Hôpitaux de Paris (APHP) and a faculty member at Sorbonne University, France. She specializes in cardiovascular diseases, with a focus on coronary artery disease and interventions. Dr. Manzo-Silberman is actively involved in clinical research, particularly in the fields of interventional cardiology and thrombosis, and she has contributed extensively to academic publications in these areas. In addition to her clinical work, she plays a key role in advancing medical education and promoting innovative cardiovascular therapies.

Profile:

Scopus Profile 

 

Education Qualification:

Dr. Stéphane Manzo-Silberman, MD, MSc, completed her medical and clinical training in cardiology at René Descartes University, Paris, where she earned her Doctorate in Medical Sciences (2005) and specialized in cardiology. She also holds a Master’s degree in Biological Sciences (2004). Her clinical expertise was further developed during her residency in internal medicine and cardiology (2000-2005), followed by advanced training as a senior resident in interventional cardiology at Cochin Hospital (2006-2011) and in coronary angiography and angioplasty at Clinique Pasteur, Toulouse (2006), under the mentorship of Pr. J Marco and Dr. J Fajadet.

Current Position:

Dr. Stéphane Manzo-Silberman currently serves as Senior Consultant at the Cardiac Catheterization Laboratory and Coronary Care Unit of the Cardiology Institute at Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris. In this role, she specializes in interventional cardiology, managing complex cardiac procedures and providing advanced care for patients with coronary artery disease. Her position reflects her expertise in cardiovascular interventions and her dedication to improving clinical outcomes in cardiology.

Awards:

Dr. Stéphane Manzo-Silberman has received several prestigious awards throughout her career, including the French Society of Cardiology Prize for the best doctorate dissertation (2005) and the French Society of Angeology Junior Prize for the best master’s dissertation (2005). She was also honored with the Young Investigator Prize at JESFC 2017 and received an ESC Grant in 2020 to attend the Women Transforming Leadership Programme, highlighting her continued excellence in cardiology and leadership development.

Research Experience:

Dr. Stéphane Manzo-Silberman serves as the principal investigator in numerous multicenter academic clinical research studies. Her work includes leading pivotal studies such as the DOLORES registry, the DeFSSICA survey on acute heart failure management, and the First French Metaregistry on gender differences in myocardial infarction. She has also co-authored the EAPCI Women’s Survey on radiation protection in catheterization labs and chaired an EAPCI position statement on radiation protection during pregnancy for healthcare professionals. Additionally, she oversees major national projects like the WAMIF study on acute myocardial infarction in young women and the ACFA study on atrial fibrillation care pathways. Dr. Manzo-Silberman also actively directs theses and dissertations, mentoring the next generation of cardiology professionals.

Conclusion:

Dr. Stéphane Manzo-Silberman stands as a prominent figure in the field of cardiology, reflecting a deep commitment to advancing cardiovascular health and understanding. His extensive research, focused on the intricate dynamics of heart disease, particularly among diverse populations, underscores the critical importance of tailored medical approaches. Through his leadership in various studies and initiatives, Dr. Manzo-Silberman not only contributes to the scientific community but also advocates for improved patient outcomes and health equity. As he continues to explore new frontiers in cardiology, his work promises to inspire future generations of medical professionals and researchers, paving the way for innovative solutions to the challenges faced in cardiovascular care.

Top Notable Publications:

Laghlam, D., Benghanem, S., Ortuno, S., Hamzaoui, O., & Aissaoui, N. (2024). Management of cardiogenic shock: A narrative review. Annals of Intensive Care, 14(1), 45.

Sabouret, P., Barbato, E., Montalescot, G., Biondi-Zoccai, G., & Manzo-Silberman, S. (2024). Remembering our friend Jean-Philippe Collet: A giant in cardiology, a gentleman in life. Minerva Cardiology and Angiology, 72(4), 329-331.

Manzo-Silberman, S., Martin, A.-C., Boissier, F., Puymirat, E., & Delmas, C. (2024). Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. Journal of Critical Care, 82, 154785.

Manzo-Silberman, S., Guedeney, P., Cayla, G., Montalescot, G., & Silvain, J. (2024). Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients with Chronic Coronary Syndrome. JACC: Cardiovascular Interventions, 17(12), 1413-1421.

Manzo-Silberman, S., Montalescot, G., & Lebreton, G. (2024). Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials? Archives of Cardiovascular Diseases (Article in Press).

Hebbo, E., Khan, S., Manzo-Silberman, S., & Alasnag, M. (2024). The Clinical Approach to Angina in Women. Interventional Cardiology Clinics (Article in Press).

Manzo-Silberman, S., & Montalescot, G. (2023). Benefits of an observatory for myocardial infarction in women under 50: The WAMIF study. Annales de Cardiologie et d’Angeiologie, 72(6), 101691.

Manzo-Silberman, S., Chouihed, T., Ticelli, L.F., Roubille, F., & El Khoury, C. (2023). Assessment of atrial fibrillation in European emergency departments: Insights from a prospective observational multicenter study. Minerva Cardiology and Angiology, 74(4), 444-455.

Weizman, O., Tea, V., Marijon, E., Simon, T., & Danchin, N. (2023). Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Archives of Cardiovascular Diseases, 116(6-7), 324-334.

Sabouret, P., Manzo-Silberman, S., Alasnag, M., Biondi-Zoccai, G., & Bhatt, D.L. (2023). New approaches to reduce recurrent PCI: To angioplasty and beyond! European Heart Journal Open, 3(3), oead049.